Addyi was very first permitted by the FDA in August 2015 to treat hypoactive sexual desire condition (HSDD) in premenopausal Girls. That is just yet another way of claiming it boosts intercourse push (also known as libido) in women who've not attained menopause. It had been the main such drug approved for this use.A second dose of ulipristal really